Delivery Order SPE2DR25D1202-SPE2DR26F71ZN
- Not listed
- The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. The contract ceiling value is $1,385.52, with an ultimate completion date of September 10, 2025. This delivery order represents a child contract executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $4,380.39 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on November 5, 2025, with completion scheduled for November 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30-unit packages. This $4,156.56 firm fixed price contract, with an ultimate completion date of November 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, and performance will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52 and completion date of July 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Orgovyx 120 mg tablets in a quantity of 30 units, with a ceiling value of $1,460.13 and a firm fixed price structure. This non-set-aside, competitively awarded delivery order is scheduled for completion by December 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,920.26 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on November 3, 2025, with completion scheduled for November 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order valued at $4,156.56 with a completion deadline of October 7, 2025. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,385.52 with completion scheduled for September 23, 2025, represents a non-competitive award issued under an existing contract vehicle. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,460.13 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units). This firm fixed-price, non-set-aside contract was awarded on November 4, 2025, with an ultimate completion date of November 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for 30 tablets of Orgovyx 120 mg with a ceiling value of $4,156.56 and a completion date of October 14, 2025. This competitively awarded, firm fixed price delivery order represents a non-set-aside procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the vendor's corporate office location in...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F71ZNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Orgovyx 120 mg tablets (30-unit packages) with a ceiling value of $2,920.26. This firm fixed-price delivery order, with an ultimate completion date of December 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award utilized no set-aside designation and was competitively awarded to the prime contractor based in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain. As a major pharmaceutical vendor, the company maintains an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for Orgovyx, an oncology medication, exemplifies the company's role in fulfilling targeted pharmaceutical requirements for federal military healthcare programs through its comprehensive global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 11/6/25 |